Overview

Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors

Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
To study the normal physiological distribution of the probe 124I-EV in human body and its ability to detect overexpression of Nectin-4 in tumor lesions.
Phase:
N/A
Details
Lead Sponsor:
Beijing Cancer Hospital
Treatments:
Fluorodeoxyglucose F18